Director, Scientific Advisory
Catalent
Sisters, Oregon
Nathan Bennette is Director, Scientific Advisory in Catalent’s global Science and Technology group and a member of Catalent’s small molecule advisory team for North America. In this capacity he works directly with partners to understand the key drug delivery objectives for their specific molecule, collaborate on the target product profile and define a strategy for the development program. He has over 12 years of experience in pharmaceutical development and delivery with an emphasis in bioavailability enhancement. Bennette is particularly interested in the application of the scientific method early in the design and development process along with improving clinical outcomes by bringing a ‘right-first-time’ approach to formulation and process design. He holds a master’s in Inorganic and Organometallic Chemistry from the University of Washington.
Disclosure information not submitted.
Tuesday, October 18, 2022
10:30 AM – 11:30 AM ET